Strategy (MSTR) prices €620M euro preferred to buy more Bitcoin as stock nears 7‑month low; options traders eye bear call spreads

Strategy (MSTR) prices €620M euro preferred to buy more Bitcoin as stock nears 7‑month low; options traders eye bear call spreads

  • New financing today: Strategy (formerly MicroStrategy) priced 7.75M shares of a 10% euro‑denominated perpetual preferred (“STRE” stock) at €80 per share, raising ~€620M gross / ~€608.8M net to fund more Bitcoin and for working capital. Dividends are cash, quarterly, with compounding if deferred (capped at 18%). Settlement is slated for Nov. 13. Contentstack
  • Market snapshot: Mid‑day Friday, MSTR traded near $230 (-3.2%) while Bitcoin hovered ~$101K. Earlier in the week, MSTR closed at $246.99, a seven‑month low after a 6.7% one‑day drop. Morningstar
  • Risk view: Despite the slide, experts told Yahoo Finance that Strategy is not at risk of a forced liquidation of its Bitcoin at current levels. Yahoo Finance
  • Options angle: Investor’s Business Daily flagged bear call spreads on MSTR as one income‑oriented way to express a cautious view while capping risk. Investors

What’s new today: a euro preferred to extend the Bitcoin war chest

Strategy Inc. (Nasdaq: MSTR) this morning priced a euro‑denominated perpetual preferred share offering—10.00% Series A Perpetual Stream Preferred Stock—at €80 per share for 7.75 million shares. Management expects ~€620 million in gross proceeds (~$715 million at €/$ 1.1534) and ~€608.8 million net, with proceeds earmarked for additional Bitcoin purchases and general corporate purposes. The company lists Barclays, Morgan Stanley, Moelis, SG Americas, TD Securities, Canaccord and StoneX as underwriters. Business Wire

A free‑writing prospectus released today details the instrument: stated amount €100 per share; 10% annual dividend paid quarterly in cash when declared; and compounded dividends that ratchet +100 bps per quarter on any unpaid amount (up to 18%) until caught up. Initial settlement is T+5 on Nov. 13. Contentstack

The filing and press release—the latest in a series of 2025 capital raises—underline Strategy’s continued approach: tap capital markets, buy more BTC, rinse and repeat. Strategy


Stock and Bitcoin move together—again

At publication time, MSTR changed hands around $229.62 (‑3.2% intraday) as Bitcoin (BTC) traded near $100,947. Earlier this week, shares closed at $246.99, the lowest since April 8, after a 6.7% drop on Tuesday as BTC briefly slipped below $100,000. Morningstar

The MSTR‑to‑BTC correlation remains the core story: when Bitcoin wobbles, Strategy’s equity typically magnifies the move because of its leveraged, BTC‑first playbook. Morningstar


Why the shares have been under pressure

MarketWatch highlighted a confluence of headwinds behind this week’s weakness: a sharper‑than‑BTC drawdown in MSTR, investor concern about continued dilution from ongoing equity and preferred issuance, and a narrowing premium of MSTR’s market value relative to the company’s BTC holdings. Tuesday’s tumble to $246.99 crystallized those concerns. Morningstar

Today’s euro preferred pricing may extend those debates. On the one hand, it diversifies funding and bolsters purchasing power if BTC rebounds. On the other, it adds a new fixed dividend obligation—albeit one the company says is payable solely in cash and can compound if delayed—raising questions about coverage should crypto weakness persist. Business Wire


The options angle: income with defined risk

For traders seeking income with capped downside, Investor’s Business Daily has spotlighted bear call spreads in MSTR—selling a call and buying a higher‑strike call with the same expiration—to benefit if shares stall or drift lower. The approach limits risk to the width of the spread minus premium received, and it can be structured above current prices to leave a buffer if MSTR chops sideways. (Options aren’t suitable for all investors.) Investors


“Won’t face Bitcoin liquidation,” says expert

While the optics of a falling stock and fresh capital raise are easy headlines, Yahoo Finance reported that an outside expert doesn’t see Strategy facing forced liquidation of its Bitcoin at current market levels. That perspective helps explain why the company leans on perpetual preferreds and equity—financing that doesn’t require pledging BTC as collateral in the way some margin structures would. Yahoo Finance


Context: MicroStrategy is now “Strategy”

If the name looks new, it is. The company rebranded from “MicroStrategy Incorporated” to “Strategy Inc.” earlier this year and completed a legal name change in August, while MSTR remains the Class A common stock ticker on Nasdaq. Strategy


What to watch next

  • Settlement (Nov. 13): Confirmation that the STRE deal closes on schedule. Business Wire
  • Dividend mechanics: The quarterly cash dividends begin Dec. 31, 2025 for STRE. Any deferral triggers compounding (up to 18%) until made whole. Business Wire
  • BTC price path: With BTC near $100K, larger swings could amplify MSTR’s moves in either direction.
  • Further issuance: 2025 has already seen multiple preferred series and shelf updates; investors will parse any new filings for size, ranking and potential dilution. Strategy

By the numbers (as of publication)

  • MSTR: $229.62 intraday; day range $220.12–$238.42.
  • BTC‑USD: $100,947; day range $99,303–$102,808.
  • STRE terms:€80 issue price; €100 stated amount; 10% coupon; quarterly cash dividends with compounding if deferred; settlement Nov. 13. Contentstack

This article is for information only and is not investment advice.

Stock Market Today

  • Phibro Animal Health Valuation: $39.44 Price vs. $43 Fair Value Signals **Undervaluation**
    January 12, 2026, 1:59 AM EST. Phibro Animal Health closed at $39.44, with a fair value near $43, implying the stock is undervalued. A 90-day return of 4.78% and a 1-year total shareholder return of 97.70% reflect momentum. The narrative rests on sustained revenue growth, higher margins and a future earnings multiple that supports the $43 fair value, though the price already prices in stronger growth than peers. The stock trades at a P/E of 23.6x vs a fair multiple of 19.6x and peers around 12.9x, raising valuation risk if earnings or sentiment cool. Risks include tighter antibiotic regulation, setbacks in new product rollouts or international expansion. Phibro Forward investments raise SG&A to fund innovation, but returns remain uncertain if growth stalls. Read the full analysis for the forecasts behind the numbers.
NIO (NIO) Today: Firefly EVs Set Sail for Europe, Austria Launch Goes Live, North America on the Map as Shares Hover Near $6.90
Previous Story

NIO (NIO) Today: Firefly EVs Set Sail for Europe, Austria Launch Goes Live, North America on the Map as Shares Hover Near $6.90

IREN Limited (NASDAQ: IREN) Posts Record Q1, Lands $9.7B Microsoft AI Cloud Deal — Stock Swings as Compass Point Doubles Target to $105 (Nov. 7, 2025)
Next Story

IREN Limited (NASDAQ: IREN) Posts Record Q1, Lands $9.7B Microsoft AI Cloud Deal — Stock Swings as Compass Point Doubles Target to $105 (Nov. 7, 2025)

Go toTop